Results 11 to 20 of about 26,721 (231)

Use of Tranexamic Acid during Total Endoprosthetic Replacement of the Hip Joint

open access: yesОбщая реаниматология, 2010
Objective: to evaluate the blood-saving activity, efficacy, and safety of tranexamic acid. Subjects and methods. Thirty-seven patients allocated into two groups were enrolled in the study of the efficacy of tranexamic acid as an agent in reducing blood ...
D. D. Selivanov   +4 more
doaj   +1 more source

Efficiency of Cardiotropic Therapy in Neonatal Infants with Posthypoxic Myocardial Damage

open access: yesОбщая реаниматология, 2011
Objective: to define the optimal tranexamic acid dosage regimen to reduce perioperative blood loss during total endo-prosthetic hip joint replacement (TEHJR). Subjects and methods.
Yu. N. Belova   +2 more
doaj   +1 more source

Tranexamic acid-induced fixed drug eruption

open access: yesIndian Journal of Dermatology, 2015
A 33-year-old male showed multiple pigmented patches on his trunk and extremities after he took tranexamic acid for common cold. He stated that similar eruptions appeared when he was treated with tranexamic acid for influenza 10 months before. Patch test
Natsuko Matsumura   +2 more
doaj   +1 more source

Tranexamic Acid for Hyperpigmentation Disorders: A Literature Review on Efficacy and Safety in Melasma and PIH. [PDF]

open access: yesJ Cosmet Dermatol
ABSTRACT Background Hyperpigmentation disorders, including melasma and post‐inflammatory hyperpigmentation (PIH), are common dermatologic conditions associated with significant cosmetic and psychological burden. Tranexamic acid (TXA), an antifibrinolytic agent, has gained increasing attention due to its anti‐inflammatory and antimelanogenic properties.
AlJabr A, AlAnazi AMI, AlEtebi RAA.
europepmc   +2 more sources

Myoclonus, Seizure, and Ventricular Fibrillation after Intrathecal Injection of Tranexamic Acid [PDF]

open access: yesJournal of Tehran University Heart Center, 2009
Tranexamic acid is generally used in the treatment of disorders that predispose one to bleeding. It is a synthetic lysine analog that has strong antifibrinolytic activity.
Abdolhamid Zokai   +2 more
doaj   +2 more sources

THE EFFECT OF TRANEXAMIC ACID INJECTION ON HEMOGLOBIN LEVEL, ALBUMIN LEVEL, AND PAIN ON PATIENT RECEIVING TOTAL KNEE REPLACEMENT

open access: yesJournal Orthopaedi and Traumatology Surabaya, 2019
Background: The high number of knee osteoarthritis cases could lead arthroplasty more frequent. Total Knee Replacement (TKR) surgery procedure is at risk of massive bleeding.
Dwikora Novembri Utomo   +3 more
doaj   +1 more source

Blood-Preserving Effect of Tranexamic Acid in Knee Joint Replacement

open access: yesОбщая реаниматология, 2008
Objective: to evaluate the efficacy and safety of tranexamic acid in knee joint replacement. Subjects and methods: the prospective open-label study of the efficacy of tranexamic acid as an agent for blood loss reduction in knee joint replacement included
Yu. L. Shevchenko   +5 more
doaj   +1 more source

Tranexamic acid dosing in pediatric trauma: Dose simulation based on population pharmacokinetic modeling in adult trauma patients. [PDF]

open access: yesTransfusion
Abstract Background Trauma is the most common cause of death in children >1 year of age, with hemorrhage being the most common preventable cause of death after injury. Antifibrinolytics like tranexamic acid (TXA) are a key aspect of trauma management in children, but optimal dosing remains unknown.
Stitt G   +5 more
europepmc   +2 more sources

Validation of the BATT score for prehospital risk stratification of traumatic haemorrhagic death: usefulness for tranexamic acid treatment criteria

open access: yesScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2021
Background Tranexamic acid reduces surgical blood loss and reduces deaths from bleeding in trauma patients. Tranexamic acid must be given urgently, preferably by paramedics at the scene of the injury or in the ambulance.
Francois-Xavier Ageron   +3 more
doaj   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy